| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |